Prostate Artery Embolization (PAE) is a novel minimally invasive angiographic technique that has been used effectively to treat men with lower urinary tract symptoms (LUTS) from benign prostatic ...

January 31, 2025 Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion. January 30, 2025 External beam radiation therapy versus radical prostatectomy for high-risk ...

Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has ...

Introduction Middle meningeal artery (MMA) embolization is becoming an increasingly established treatment option for chronic subdural hematoma (cSDH). Although several systematic reviews have ...

Background The periprocedural management of antithrombotic medications in patients with chronic subdural hematoma (cSDH) after middle meningeal artery embolization (MMAE) or surgical evacuation is ...

Middle meningeal artery embolization (MMAe) is increasingly utilized as a primary or secondary treatment for chronic subdural hematoma (cSDH) and is usually performed with liquid embolics. Outcomes ...

Hence, in that case, Prostate Artery Embolization (PAE), a minimally invasive procedure is preferred. “PAE involves inserting a tiny catheter into the femoral artery and releasing embolic ...

According to the company, the RESORB trial is being conducted to achieve market approval for Nexsphere-F for genicular artery embolization (GAE) to treat osteoarthritis-related symptoms. The device is ...

Jan. 28, 2025 — The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to a new ... Jan. 3, 2025 — In ...